×
About 12,493 results

ALLMedicine™ Eosinophils Center

Research & Reviews  6,107 results

Mucosal eosinophils, mast cells, and intraepithelial lymphocytes in youth with ruminati...
https://doi.org/10.1111/nmo.14155
Neurogastroenterology and Motility : the Official Journal... Friesen HJ, Rosen J et. al.

Apr 10th, 2021 - Rumination syndrome has been associated with increased duodenal eosinophils and intraepithelial lymphocytes in adults. The aims of the current study were to assess densities of antroduodenal eosinophils and mast cells and duodenal intraepithelial ...

The pharmacology of the prostaglandin D2 receptor 2 (DP2) receptor antagonist, fevipipr...
https://doi.org/10.1016/j.pupt.2021.102030
Pulmonary Pharmacology & Therapeutics; Brightling C, Kulkarni S et. al.

Apr 7th, 2021 - Fevipiprant is an oral, non-steroidal, highly selective, reversible antagonist of the prostaglandin D2 (DP2) receptor. The DP2 receptor is a mediator of inflammation expressed on the membrane of key inflammatory cells, including eosinophils, Th2 c...

Predictive factors for identifying macrolide responder in treating chronic rhinosinusitis.
https://doi.org/10.4193/Rhin20.649
Rhinology Seresirikachorn K, Kerr SJ et. al.

Apr 6th, 2021 - Low-dose macrolides (LDM) are anti-inflammatory agents with antineutrophilic activity, but patient selection for LDM therapy in treating chronic rhinosinusitis (CRS) is controversial. This study aimed to assess factors which predict LDM responders...

High Blood Eosinophil and YKL-40 Levels, as Well as Low CXCL9 Levels, are Associated wi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009765
International Journal of Chronic Obstructive Pulmonary Di... Peng J, Yu Q et. al.

Apr 5th, 2021 - Readmission after hospital discharge is common among patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Predictive biomarkers of readmission would facilitate stratification strategies and individualized prognosis. ...

The interplay between airway epithelium and the immune system - A primer for the respir...
https://doi.org/10.1016/j.prrv.2021.03.002
Paediatric Respiratory Reviews; Weinstock J, Chen XX et. al.

Apr 4th, 2021 - The respiratory epithelium is one of the primary interfaces between the body's immune system and the external environment. This review discusses the innate and adaptive immunomodulatory effects of the respiratory epithelium, highlighting the physi...

see more →

Guidelines  1 results

Management guidelines of eosinophilic esophagitis in childhood.
https://doi.org/10.1097/MPG.0b013e3182a80be1
Journal of Pediatric Gastroenterology and Nutrition; Papadopoulou A, Koletzko S et. al.

Dec 31st, 2013 - Eosinophilic esophagitis (EoE) represents a chronic, immune/antigen-mediated esophageal disease characterized clinically by symptoms related to esophageal dysfunction and histologically by eosinophil-predominant inflammation. With few exceptions, ...

see more →

Clinicaltrials.gov  6,205 results

Mucosal eosinophils, mast cells, and intraepithelial lymphocytes in youth with ruminati...
https://doi.org/10.1111/nmo.14155
Neurogastroenterology and Motility : the Official Journal... Friesen HJ, Rosen J et. al.

Apr 10th, 2021 - Rumination syndrome has been associated with increased duodenal eosinophils and intraepithelial lymphocytes in adults. The aims of the current study were to assess densities of antroduodenal eosinophils and mast cells and duodenal intraepithelial ...

The pharmacology of the prostaglandin D2 receptor 2 (DP2) receptor antagonist, fevipipr...
https://doi.org/10.1016/j.pupt.2021.102030
Pulmonary Pharmacology & Therapeutics; Brightling C, Kulkarni S et. al.

Apr 7th, 2021 - Fevipiprant is an oral, non-steroidal, highly selective, reversible antagonist of the prostaglandin D2 (DP2) receptor. The DP2 receptor is a mediator of inflammation expressed on the membrane of key inflammatory cells, including eosinophils, Th2 c...

Predictive factors for identifying macrolide responder in treating chronic rhinosinusitis.
https://doi.org/10.4193/Rhin20.649
Rhinology Seresirikachorn K, Kerr SJ et. al.

Apr 6th, 2021 - Low-dose macrolides (LDM) are anti-inflammatory agents with antineutrophilic activity, but patient selection for LDM therapy in treating chronic rhinosinusitis (CRS) is controversial. This study aimed to assess factors which predict LDM responders...

High Blood Eosinophil and YKL-40 Levels, as Well as Low CXCL9 Levels, are Associated wi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009765
International Journal of Chronic Obstructive Pulmonary Di... Peng J, Yu Q et. al.

Apr 5th, 2021 - Readmission after hospital discharge is common among patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Predictive biomarkers of readmission would facilitate stratification strategies and individualized prognosis. ...

The interplay between airway epithelium and the immune system - A primer for the respir...
https://doi.org/10.1016/j.prrv.2021.03.002
Paediatric Respiratory Reviews; Weinstock J, Chen XX et. al.

Apr 4th, 2021 - The respiratory epithelium is one of the primary interfaces between the body's immune system and the external environment. This review discusses the innate and adaptive immunomodulatory effects of the respiratory epithelium, highlighting the physi...

see more →

News  175 results

Fast Five Quiz: Type 2 Inflammation in Severe Asthma
https://reference.medscape.com/viewarticle/943837

Jan 19th, 2021 - Asthma is a heterogeneous chronic disease characterized by narrowing of airways of the lungs and can lead to debilitating symptoms. Type 2 inflammation in asthma is noted by the release of inflammatory cytokines, including interleukin (IL)-4, IL-5...

Benralizumab Improves Health-Related Quality of Life in Severe Eosinophilic Asthma
https://www.medscape.com/viewarticle/944191

Jan 18th, 2021 - NEW YORK (Reuters Health) - Results of a phase-3b trial confirm and extend the efficacy of benralizumab for patients with severe eosinophilic asthma, showing early and sustained improvements in patient-reported outcomes, lung function, asthma cont...

Uncontrolled Asthma: Dupilumab Shows Efficacy Regardless of Disease Severity
https://www.medscape.com/viewarticle/943427

Jan 3rd, 2021 - Takeaway In patients with uncontrolled, moderate-to-severe asthma and elevated baseline eosinophils, dupilumab reduced severe exacerbations and improved lung function, asthma control and quality of life (QoL), regardless of their baseline disease ...

A 40-Year-Old Man With Bumps on His Neck: Osmosis USMLE Study Question
https://www.staging.medscape.com/viewarticle/891233_2

Oct 1st, 2020 - The patient in this question most likely has Hodgkin lymphoma, a B-cell lymphoma characterized by a proliferation of Reed-Sternberg cells (B-cells) in a reactive cellular background. Reed-Sternberg cells secrete cytokines that lead to immunologic ...

Fast Five Quiz: Test Your Knowledge of Severe Asthma
https://reference.medscape.com/viewarticle/896418_6

May 17th, 2020 - Mepolizumab is a humanized immunoglobulin G1 kappa monoclonal antibody specific for interleukin 5 (IL-5). Mepolizumab binds to IL-5 and therefore stops IL-5 from binding to its receptor on the surface of eosinophils. Inhibiting IL-5 binding to eos...

see more →

Patient Education  5 results see all →